Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 3, 2010, Pages 571-577

  Chae, Yee Soo ^a   Kim, Jong Gwang ^a   Sohn, Sang Kyun ^a   Moon, Joon Ho ^a   Kim, Shi Nae ^a   Lee, Su Jeong ^a   Park, Tae In ^a   Lee, Myung Hoon ^b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Apoptosis related gene; Diffuse large B cell lymphoma; Polymorphism; Prognosis; R CHOP

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GENOMIC DNA; LYMPHOTOXIN; PREDNISOLONE; PROTEIN RIPK1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; PREDNISONE; RIPK1 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; ADOLESCENT; DISEASE COURSE; GENE FREQUENCY; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TIME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; GENE FREQUENCY; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDNISONE; PROGNOSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TIME FACTORS; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 75549088494     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1066-x     Document Type: Article

References (33)

1. B Coiffier E Lepage J Briere R Herbrecht H Tilly R Bouabdallah P Morel E Van Den Neste G Salles P Gaulard F Reyes P Lederlin C Gisselbrecht 2002 CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B cell lymphoma N Engl J Med 346 235 242 10.1056/NEJMoa011795 1:CAS:528:DC%2BD38XmslGgsw%3D%3D 11807147 (Pubitemid 34438862)
2. P Feugier A Van Hoof C Sebban P Solal-Celigny R Bouabdallah C Ferme B Christian E Lepage H Tilly F Morschhauser P Gaulard G Salles A Bosly C Gisselbrecht F Reyes B Coiffier 2005 Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 23 4117 4126 10.1200/JCO.2005.09.131 1:CAS:528:DC%2BD2MXmt1elsr0%3D 15867204 (Pubitemid 46211317)
3. M Pfreundschuh L Trumper A Osterborg R Pettengell M Trneny K Imrie D Ma D Gill J Walewski PL Zinzani R Stahel S Kvaloy O Shpilberg U Jaeger M Hansen T Lehtinen A Lopez-Guillermo C Corrado A Scheliga N Milpied M Mendila M Rashford E Kuhnt M Loeffler 2006 CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 379 391 10.1016/S1470-2045(06)70664-7 1:CAS:528:DC%2BD28XjvFWlsbw%3D 16648042
4. DR Anderson A Grillo-Lopez C Varns KS Chambers N Hanna 1997 Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B cell lymphoma Biochem Soc Trans 25 705 708 1:CAS:528:DyaK2sXjs1ant7w%3D 9191187 (Pubitemid 27260903)
5. RA Clynes TL Towers LG Presta JV Ravetch 2000 Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets Nat Med 6 443 446 10.1038/74704 1:CAS:528:DC%2BD3cXisVOru7Y%3D 10742152 (Pubitemid 30208162)
6. ME Reff K Carner KS Chambers PC Chinn JE Leonard R Raab RA Newman N Hanna DR Anderson 1994 Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood 83 435 445 1:CAS:528:DyaK2cXhtVCnu70%3D 7506951
7. PA Ellis IE Smith K McCarthy S Detre J Salter M Dowsett 1997 Preoperative chemotherapy induces apoptosis in early breast cancer Lancet 349 849 10.1016/S0140-6736(05)61752-7 1:STN:280:DyaK2s3js1yltA%3D%3D 9121265 (Pubitemid 27129217)
8. JF Kerr CM Winterford BV Harmon 1994 Apoptosis: its significance in cancer and cancer therapy Cancer 73 2013 2026 10.1002/1097-0142(19940415)73: 8<2013::AID-CNCR2820730802>3.0.CO;2-J 1:CAS:528:DyaK2cXksl2lt70%3D 8156506
9. M Thomas A Kalita S Labrecque D Pim L Banks G Matlashewski 1999 Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 19 1092 1100 1:CAS:528:DyaK1MXhtVKhsL0%3D 9891044
10. P Dumont JI Leu AC Della Pietra 3rd DL George M Murphy 2003 The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 357 365 10.1038/ng1093 1:CAS:528:DC%2BD3sXhsV2ktbc%3D 12567188 (Pubitemid 36278852)
11. P Rajaraman SS Wang N Rothman MM Brown PM Black HA Fine JS Loeffler RG Selker WR Shapiro SJ Chanock PD Inskip 2007 Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults Cancer Epidemiol Biomarkers Prev 16 1655 1661 10.1158/1055-9965.EPI-07-0314 1:CAS:528: DC%2BD2sXos1Cjsro%3D 17684142 (Pubitemid 47294834)
12. JG Kim SK Sohn YS Chae YY Cho HI Bae G Yan JY Park MH Lee HY Chung W Yu 2007 Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer Ann Oncol 18 1030 1036 10.1093/annonc/mdm085 1:STN:280:DC%2BD2szntVamtw%3D%3D 17426061 (Pubitemid 47050494)
13. BD Cheson SJ Horning B Coiffier MA Shipp RI Fisher JM Connors TA Lister J Vose A Grillo-Lopez A Hagenbeek F Cabanillas D Klippensten W Hiddemann R Castellino NL Harris JO Armitage W Carter R Hoppe GP Canellos 1999 Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas NCI Sponsored International Working Group J Clin Oncol 17 1244 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D 10561185
14. PS Schwartz DJ Waxman 2001 Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells Mol Pharmacol 60 1268 1279 1:CAS:528: DC%2BD3MXovVOit7s%3D 11723234
15. S Gamen A Anel P Perez-Galan P Lasierra D Johnson A Pineiro J Naval 2000 Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells Exp Cell Res 258 223 235 10.1006/excr.2000.4924 1:CAS:528:DC%2BD3cXkt1Kgs7c%3D 10912804 (Pubitemid 30461124)
16. JD Robertson V Gogvadze B Zhivotovsky S Orrenius 2000 Distinct pathways for stimulation of cytochrome c release by etoposide J Biol Chem 275 32438 32443 10.1074/jbc.C000518200 1:CAS:528:DC%2BD3cXnslOisbk%3D 10961984
17. X Zhou W Hu X Qin 2008 The role of complement in the mechanism of action of rituximab for B cell lymphoma: implications for therapy Oncologist 13 954 966 10.1634/theoncologist.2008-0089 1:CAS:528:DC%2BD1cXhtlaksrrM 18779537
18. RW Johnstone AA Ruefli SW Lowe 2002 Apoptosis: a link between cancer genetics and chemotherapy Cell 108 153 164 10.1016/S0092-8674(02)00625-6 1:CAS:528:DC%2BD38XhtV2hsLk%3D 11832206 (Pubitemid 34161136)
19. S Kitada IM Pedersen AD Schimmer JC Reed 2002 Dysregulation of apoptosis genes in hematopoietic malignancies Oncogene 21 3459 3474 10.1038/sj.onc.1205327 1:CAS:528:DC%2BD38XksVWrtr4%3D 12032782 (Pubitemid 34587716)
20. M Zodelava I Datikashvili-David 2005 Prognostic significance of apoptosis-related CD95 antigen expression in patients with non-Hodgkin's lymphoma Georgian Med News 3 7 9
21. H Yasuda K Sugimoto H Imai Y Isobe M Sasaki Y Kojima S Nakamura K Oshimi 2009 Expression levels of apoptosis-related proteins and Ki-67 in nasal NK/T cell lymphoma Eur J Haematol 82 39 45 10.1111/j.1600-0609.2008.01152.x 18778369
22. RL ten Berge CJ Meijer DF Dukers JA Kummer BA Bladergroen W Vos CE Hack GJ Ossenkoppele JJ Oudejans 2002 Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma Blood 99 4540 4546 10.1182/blood.V99.12.4540 1:CAS:528:DC%2BD38XksFGksLw%3D 12036886 (Pubitemid 34627225)
23. SK Sohn JT Jung DH Kim JG Kim EK Kwak T Park DG Shin KR Sohn KB Lee 2003 Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B cell lymphoma Am J Hematol 73 101 107 10.1002/ajh.10333 1:CAS:528: DC%2BD3sXkslGjtbg%3D 12749011 (Pubitemid 36578431)
24. PJ Jost J Ruland 2007 Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications Blood 109 2700 2707 1:CAS:528:DC%2BD2sXjvVygu7Y%3D 17119127
25. M Karin A Lin 2002 NF-kB at the crossroads of life and death Nat Immunol 3 221 227 10.1038/ni0302-221 1:CAS:528:DC%2BD38XitVWlt7g%3D 11875461 (Pubitemid 34213423)
26. K Warzocha P Ribeiro J Bienvenu P Roy C Charlot D Rigal B Coiffier G Salles 1998 Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome Blood 91 3574 3581 1:CAS:528:DyaK1cXjtFersro%3D 9572991
27. K Seidemann M Zimmermann M Book U Meyer B Burkhardt K Welte A Reiter M Stanulla 2005 Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM 95 J Clin Oncol 23 8414 8421 10.1200/JCO.2005.01.2179 1:CAS:528:DC%2BD2MXhtlWhtrbM 16293872 (Pubitemid 46264011)
28. K Takei S Ikeda T Arai N Tanaka M Muramatsu M Sawabe 2008 Lymphotoxin-alpha polymorphisms and presence of cancer in 1, 536 consecutive autopsy cases BMC Cancer 8 235 10.1186/1471-2407-8-235 18700950
29. Y Niwa H Ito K Matsuo K Hirose N Ito M Mizuno N Hamajima K Tajima T Nakanishi 2007 Lymphotoxin-alpha polymorphisms and the risk of endometrial cancer in Japanese subjects Gynecol Oncol 104 586 590 10.1016/j.ygyno.2006.09. 007 1:CAS:528:DC%2BD2sXitFOgsLk%3D 17045328 (Pubitemid 46240238)
30. K Ozaki Y Ohnishi A Iida A Sekine R Yamada T Tsunoda H Sato H Sato M Hori Y Nakamura T Tanaka 2002 Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction Nat Genet 32 650 654 10.1038/ng1047 1:CAS:528:DC%2BD38XptVShurg%3D 12426569 (Pubitemid 35435179)
31. G Messer U Spengler MC Jung G Honold K Blomer GR Pape G Riethmuller EH Weiss 1991 Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production J Exp Med 173 209 219 10.1084/jem.173.1.209 1:CAS:528:DyaK3MXls1Oksg%3D%3D 1670638
32. H Hsu J Huang HB Shu V Baichwal DV Goeddel 1996 TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex Immunity 4 387 396 10.1016/S1074-7613(00)80252-6 1:CAS:528:DyaK28Xis1GmsLo%3D 8612133 (Pubitemid 26174054)
33. P Jagiello M Gencik L Arning S Wieczorek E Kunstmann E Csernok WL Gross JT Epplen 2004 New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes Hum Genet 114 468 477 10.1007/s00439-004-1092-z 1:CAS:528:DC%2BD2cXisFSru7k%3D 14968360 (Pubitemid 38678925)